_(3).png)
_(4).png){kind=logo}
Loading Shopping Cart Items...
Description: High-throughput technologies such as next-generation genomics, transcriptomics and proteomics are capable of generating massive amounts of data quickly, and at relatively low costs. It is tempting to use this data for various medical applications including preclinical disease detection and for prediction of disease predisposition. In this webinar, the speaker will illustrate the opportunities and challenges that will be faced when delivering these omics technologies to improving patient care. The webinar will be of value to both clinical chemists and medical geneticists.
Start date: Upon registration
Completion: Up to 52 weeks
At the end of this webinar you will be able to:
Speaker: Vathany Kulasingam, PhD, FCACB
Dr. Vathany Kulasingam is Division Head of Clinical Biochemistry at University Health Network and is an Associate Professor in the Department of Laboratory Medicine and Pathobiology at the University of Toronto. She is the Co-Director of the Postdoctoral Training Program in Clinical Chemistry. Her research interests include using high-throughput “omics” technologies to understand disease pathogenesis, with a particular emphasis on cancer and rheumatic diseases and its application to clinical practice. She has collaborated extensively with numerous organizations including AACC – now called ADLM, CLSI and the IVD industry.
Recorded: November 18, 2023
PEP hours: 1.0
CPS credits: 0
*Note: PEP hours and/or CPS credits will only be awarded upon successful completion of the quiz.
Loading Shopping Cart Items...